Track bills, resolutions, and amendments moving through Congress
Kay Hagan Tick Reauthorization Act
The bill maintains and extends federal support and program continuity for vector-borne disease surveillance, research, and training through 2030—benefiting state/local public health and hospitals—but increases federal spending and shifts language that could centralize decision-making and reduce transparency for external partners.
National Plan for Epilepsy Act
The bill centralizes and coordinates federal action on epilepsy — improving research, care, and patient input — but will likely require new spending, create administrative and privacy burdens, and may take time to deliver benefits unless further statutory changes are made.
Youth Poisoning Protection Act
The bill reduces public access to a dangerous chemical—potentially preventing accidental poisonings and some suicides—at the cost of compliance burdens for businesses, possible higher prices or shortages for some consumer products, and some regulatory complexity between agencies.
To reauthorize the Young Women’s Breast Health Education and Awareness Requires Learning Young Act of 2009.
The bill modernizes and authorizes federal breast and cervical cancer screening efforts—adding quality, navigation, and evidence‑based approaches and signaling stable funding—while creating legal, coverage-predictability, and fiscal risks that could limit consistent access and state implementation, especially for low-income women.
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
The bill seeks to speed and better-account for development of ALS and rare neurodegenerative therapies through expanded funding, safety reporting, and an FDA action plan, while trading off higher federal costs, new burdens on researchers, and some uncertainty or potential delays for certain trials.
National Defense Authorization Act for Fiscal Year 2027
The bill funds broad improvements to military readiness, health care, industrial base resilience, and technology adoption—but does so at the cost of higher federal spending, increased administrative and reporting burdens, privacy and oversight risks, and potential supply‑chain and competition tradeoffs.
NIH IMPROVE Act
The bill directs multi-year federal funding to generate research and targeted interventions that could reduce maternal mortality and address disparities over time, but requires ongoing taxpayer investment and may deliver limited near-term relief if funds emphasize research over immediate community programs.
To amend the Research and Development, Competition, and Innovation Act to support nucleic acid screening, and for other purposes.
The bill coordinates and funds standards, tools, and security guidance to make nucleic-acid screening more reliable and harder to misuse, while imposing compliance costs and creating a federal-centered consensus process that may advantage larger, well-funded actors and requires modest new federal spending.
Destruction of Hazardous Imports Act
The bill strengthens public‑health protections by forcing removal and destruction of dangerous imported goods and imposing strict agency deadlines, but it shifts costs and legal risks onto importers (especially small businesses), may briefly leave a regulatory gap, and could strain agency resources.
Action for Dental Health Act
The bill provides modest, multi-year, flexible funding for HHS public health programs through FY2030 to bolster preparedness, at the cost of a small annual increase in federal outlays and potential timing risks for grantees if appropriations are not aligned.
To reauthorize and make improvements to Federal programs relating to the prevention, detection, and treatment of traumatic brain injuries, and for other purposes.
The bill strengthens TBI surveillance, prevention, funding authorization, and public reporting to improve care and reduce injuries, but it shifts fiscal and administrative burdens onto states and tribes, raises privacy and implementation risks, and depends on future appropriations to realize its benefits.
Stem Cell Therapeutic and Research Reauthorization Act of 2025
The bill sustains and modestly increases federal support for cord blood/stem‑cell inventory through FY2027–2031—improving patient access and program stability—while increasing potential federal costs and giving the Secretary broad discretion that could lead to unit transfers/discards and uncertainty for smaller banks and clinicians.
To reauthorize the Kay Hagan Tick Act, and for other purposes.
The bill maintains and strengthens federal support for detecting and responding to vector‑borne diseases through 2030—protecting public health and program continuity—while increasing federal spending and slightly reducing stakeholder transparency about advisory roles.
Older Americans Act Reauthorization Act of 2025
The bill strengthens coordination, transparency, and direct supports for older adults (behavioral health, caregivers, nutrition, tribal elders, abuse prevention) but does so at the cost of substantial new administrative requirements, potential funding strains and reallocations, and some privacy, equity, and oversight trade-offs.
Lulu’s Law
The bill improves public safety by providing shark-warning alerts to protect beachgoers, but does so at the cost of more frequent alerts that could cause public alert fatigue and create operational burdens for emergency agencies.
Gerald E. Connolly Esophageal Cancer Awareness Act of 2025
The bill aims to raise awareness and target screening to detect esophageal cancers earlier—potentially saving lives and improving program transparency—while risking higher demand and costs, capacity strain, and possible inequities from demographic-targeted screening.
Women and Lung Cancer Research and Preventive Services Act of 2025
The bill promotes increased lung cancer screening, targeted research, and federal transparency—potentially improving outcomes (especially for women and under-recognized groups)—but will consume federal resources, may raise short-term healthcare costs, and may require further legislation/funding to realize its full benefits.
PIPELINE Safety Act of 2025
The bill boosts pipeline safety and modernization—providing funding, improved oversight, technical studies, and new inspection tools—while increasing federal spending, imposing significant compliance and administrative burdens, and narrowing public access to some safety information, trading faster modernization and industry cooperation against higher costs and reduced transparency/accountability.
Protect Infant Formula from Contamination Act
The bill increases reporting, transparency, and FDA powers to speed investigations and prevent contaminated infant formula from reaching babies—improving safety and shortage monitoring—at the cost of higher compliance burdens and proprietary risk for manufacturers, potential short‑term supply disruptions, and additional strain on FDA resources (and possibly taxpayer funding).
Improving Care in Rural America Reauthorization Act of 2025
The bill sustains and directs federal grant support to expand and better-coordinate rural health services and increase community input, while creating modest new administrative burdens and preserving ongoing federal spending that may limit funding flexibility.
Women and Lung Cancer Research and Preventive Services Act of 2025
The bill prioritizes coordinated federal review, targeted outreach, and research collaboration to expand lung cancer screening and improve diagnostics—especially for women and underserved groups—while risking a roughly two-year delay before changes take effect and incurring additional federal costs.
Mystic Alerts Act
The bill expands the reach of emergency alerts via satellite and limits consumer fees and provider legal risk to encourage participation, but benefits may be uneven due to device compatibility, voluntary provider participation, privacy risks, and reduced user recourse.
Muhammad Ali American Boxing Revival Act of 2026
The bill substantially raises fighter safety and baseline pay protections while increasing operating and compliance costs — benefiting boxers’ health and incomes but likely concentrating events, raising prices, and creating regulatory complexity across jurisdictions.
Tyler’s Law
The bill aims to improve emergency overdose diagnosis and support hospitals with federal guidance and training insights, but does so at the cost of new implementation expenses, added privacy burdens, and the risk of routine testing without clear benefit that could undermine patient trust.
Designating November 2025 as "National Lung Cancer Awareness Month" and expressing support for early detection and treatment of lung cancer.
The resolution could boost lung cancer detection and access to precision treatments—improving outcomes for high‑risk adults and veterans—but will increase costs, strain providers, and may worsen existing access disparities unless funding and equity are actively addressed.
To amend the John D. Dingell, Jr. Conservation, Management, and Recreation Act to reauthorize the National Volcano Early Warning and Monitoring System.
The bill provides continuity and predictable, modest funding for volcanic monitoring and early warning through 2029, but caps funding at $470,000/year which may leave monitoring needs underfunded while imposing a small new federal cost and minor administrative adjustments.
Veterinary Services to Improve Public Health in Rural Communities Act
The bill improves tribal veterinary public‑health capacity, One Health coordination, and tribal representation in preparedness, but largely does so without guaranteed new funding and will require administrative capacity and time to translate studies and coordination into concrete, funded protections.
Designating November 30, 2025, as "Drive Safer Sunday".
SUPPORT for Patients and Communities Reauthorization Act of 2025
The bill substantially increases federal investments, program scope, and workforce and medication‑access reforms to prevent overdoses and expand treatment, but it raises fiscal costs, administrative burdens, privacy and legal uncertainties, and implementation risks that must be managed to realize intended benefits.
Bottles and Breastfeeding Equipment Screening Enhancement Act
The bill strengthens hygiene protections and oversight for infant items at airport security—better protecting infants and standardizing practices—but it may increase screening times, impose costs on airports/contractors (possibly passed to travelers), and leave short-term gaps if guidance isn’t uniformly enforced.
